Lv41
666 积分 2025-12-20 加入
Gut Microbiota-Mediated Pharmacokinetic Drug–Drug Interactions between Mycophenolic Acid and Trimethoprim-Sulfamethoxazole in Humans
2小时前
已完结
Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-Microbiome Study
2小时前
已完结
Pharmacodynamics of 250 mg and 500 mg oral furosemide in peritoneal dialysis
2天前
已完结
Pharmacokinetics of rosuvastatin in patients with end-stage kidney disease undergoing peritoneal dialysis
2天前
已完结
Efavirenz dosing in patients receiving continuous ambulatory peritoneal dialysis
1个月前
已关闭
Chronic kidney disease and physiologically based pharmacokinetic modeling: a critical review of existing models
2个月前
已完结
Prevalence of Chronic Kidney Disease in China
2个月前
已完结
Nonrenal Drug Clearance in CKD: Searching for the Path Less Traveled
2个月前
已完结
Pharmacokinetics of efavirenz in a patient on maintenance haemodialysis
2个月前
已关闭
Sex-Specific Associations Between Diabetes Mellitus and Hearing Loss in the Middle-Aged and Elderly Individuals: A National Cohort Study of Chinese Adults
3个月前
已完结
皖公网安备34019202002308
